Clinical trial
Vaccine Therapy in Treating Patients With Ovarian Epithelial or Primary…
NCT00091273 · University of Virginia, Other · Completed
Key facts
| NCT number | NCT00091273 |
|---|---|
| Title | Vaccine Therapy in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer |
| Official title | Evaluation of Safety and Immunogenicity of a Peptide Vaccine in Patients With Epithelial Ovarian or Primary Peritoneal Cancer |
| Lead sponsor | University of Virginia, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Ovarian Cancer, Primary Peritoneal Cavity Cancer |
| Intervention type | Biological, Procedure |
| Interventions | incomplete Freund's adjuvant, ovarian cancer peptide vaccine, sargramostim, tetanus toxoid helper peptide, adjuvant therapy |
| Enrollment | 9 |
| Start date | Jun 1, 2004 |
| Primary completion | Feb 1, 2006 |
| Completion | Jun 1, 2007 |
| First posted | Sep 9, 2004 |
| Last update posted | Jun 20, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: